Ginkgo Bioworks Hldgs Inc (DNA)
13.41 x 1 13.72 x 1
Post-market by (Cboe BZX)
13.55 +1.23 (+9.98%) 02/13/25 [NYSE]
13.41 x 1 13.72 x 1
Post-market 13.50 -0.05 (-0.37%) 19:38 ET
for Thu, Feb 13th, 2025
Results
download Want to compare other data? Select FieldsSymbol | DNA | BCAX | LENZ | ||
Company | Ginkgo Bioworks Hldgs Inc | Bicara Therapeutics Inc | Lenz Therapeutics Inc | ||
Price Information | |||||
Exchange | NYSE | NASDAQ | NASDAQ | ||
Open | 12.68 | 13.41 | 25.21 | ||
High | 13.60 | 13.41 | 25.45 | ||
Low | 12.01 | 12.50 | 24.41 | ||
Last | 13.55 | 13.12 | 25.28 | ||
Change | +1.23 | -0.10 | +0.44 | ||
% Change | +9.98% | -0.76% | +1.77% | ||
Volume | 1,322,081 | 162,700 | 48,600 | ||
20-Day Average Volume | 1,633,880 | 340,085 | 130,720 | ||
Previous Close | 12.32 | 13.22 | 24.84 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 12.92 | 12.34 | 24.99 | ||
20-Day Raw Stochastic | 57.85% | 71.89% | 64.38% | ||
20-Day Relative Strength | 55.62% | 42.90% | 44.79% | ||
Weighted Alpha | -71.16 | N/A | +20.09 | ||
Today's Opinion | 56% Buy | N/A | 8% Sell | ||
Previous Opinion | 24% Buy | N/A | 8% Sell | ||
Last Month's Opinion | 32% Sell | N/A | 8% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -0.95% since 02/06/25 | +4.13% since 02/06/25 | -5.28% since 02/06/25 | ||
Low | 11.21 on 02/12/25 | 11.64 on 02/11/25 | 23.92 on 02/10/25 | ||
High | 14.80 on 02/07/25 | 13.57 on 02/12/25 | 26.67 on 02/07/25 | ||
1-Month | |||||
%Chg | +52.93% since 01/13/25 | +1.00% since 01/13/25 | +8.97% since 01/13/25 | ||
Low | 8.44 on 01/14/25 | 11.10 on 01/28/25 | 21.34 on 01/16/25 | ||
High | 16.85 on 02/06/25 | 13.97 on 01/15/25 | 27.46 on 01/31/25 | ||
3-Month | |||||
%Chg | +57.56% since 11/13/24 | -40.36% since 11/13/24 | -30.43% since 11/13/24 | ||
Low | 6.01 on 11/15/24 | 11.10 on 01/28/25 | 21.34 on 01/16/25 | ||
High | 16.85 on 02/06/25 | 24.09 on 11/15/24 | 38.77 on 11/27/24 | ||
6-Month | |||||
%Chg | +20.59% since 08/13/24 | N/A since 09/13/24 | +9.11% since 08/13/24 | ||
Low | 5.26 on 09/10/24 | 11.10 on 01/28/25 | 19.90 on 09/12/24 | ||
High | 16.85 on 02/06/25 | 28.09 on 11/06/24 | 38.93 on 11/13/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 708,141 | 719,380 | 683,125 | ||
Shares Outstanding, K | 57,479 | 54,416 | 27,501 | ||
Annual Sales | 251,460,000 | 0 | 15,000,000 | ||
Annual Net Income | -892,870,000 | -51,985,000 | -124,650,000 | ||
Last Quarter Sales | 89,050,000 | 0 | 0 | ||
Last Quarter Net Income | -56,400,000 | -17,481,000 | -10,220,000 | ||
60-Month Beta | 1.16 | N/A | 0.56 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.08 on 11/12/24 | -1.60 on 11/12/24 | -0.38 on 11/06/24 | ||
Latest Earnings Date | 03/06/25 | 02/11/25 | 02/19/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |